TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $293,000 | -24.1% | 143,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $386,000 | +17.3% | 143,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $329,000 | -31.3% | 143,000 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $479,000 | +6.4% | 143,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $450,000 | -16.0% | 143,000 | 0.0% | 0.01% | -20.0% |
| Q1 2017 | $536,000 | -23.5% | 143,000 | 0.0% | 0.01% | -37.5% |
| Q4 2016 | $701,000 | -27.5% | 143,000 | 0.0% | 0.02% | -30.4% |
| Q3 2016 | $967,000 | +54.5% | 143,000 | 0.0% | 0.02% | +43.8% |
| Q2 2016 | $626,000 | -44.7% | 143,000 | -12.3% | 0.02% | -42.9% |
| Q1 2016 | $1,133,000 | -31.9% | 163,000 | -9.4% | 0.03% | -36.4% |
| Q4 2015 | $1,663,000 | +25.8% | 180,000 | +33.0% | 0.04% | +37.5% |
| Q3 2015 | $1,322,000 | -6.6% | 135,300 | +8.2% | 0.03% | +10.3% |
| Q2 2015 | $1,416,000 | -19.3% | 125,000 | 0.0% | 0.03% | -17.1% |
| Q1 2015 | $1,755,000 | – | 125,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 4,601,768 | $2,899,000 | 3.31% |
| Telemetry Investments, L.L.C. | 966,975 | $609,000 | 0.39% |
| 683 Capital Management, LLC | 2,738,938 | $1,726,000 | 0.10% |
| Anson Funds Management LP | 250,182 | $158,000 | 0.09% |
| NEA Management Company, LLC | 3,467,181 | $2,184,000 | 0.09% |
| LINDEN ADVISORS LP | 2,842,477 | $1,791,000 | 0.05% |
| X-Square Capital, LLC | 79,198 | $50,000 | 0.04% |
| QVT Financial LP | 23,351 | $15,000 | 0.01% |
| BHK Investment Advisors, LLC | 10,000 | $6,000 | 0.01% |
| Virtu Financial LLC | 18,233 | $11,000 | 0.00% |